Table 4.
Euthyroid | Persistent subclinical hypothyroid | Transient subclinical hypothyroid | |
---|---|---|---|
CHD | |||
No. of events/no. at risk | 431/1749 | 51/156 | 22/91 |
Incidence (95% CI) per 1000 person-years | 32.9 (30.0–36.2) | 46.1 (35.1–60.7) | 32.1 (21.2–48.8) |
HR (95% CI) | 1.0 | 1.37 (1.00–1.87) | 1.00 (0.65–1.53) |
HF | |||
No. of events/no. at risk | 476/2155 | 42/193 | 27/117 |
Incidence (95% CI) per 1000 person-years | 29.3 (26.8–32.1) | 29.4 (21.7–39.8) | 30.5 (20.9–44.4) |
HR (95% CI) | 1.0 | 0.89 (0.63–1.25) | 1.01 (0.68–1.49) |
CV death | |||
No. of events/no. at risk | 394/2298 | 45/206 | 24/129 |
Incidence (95% CI) per 1000 person-years | 21.4 (19.4–23.6) | 27.7 (20.7–37.1) | 23.2 (15.5–34.6) |
HR (95% CI) | 1.0 | 0.97 (0.64–1.48) | 0.99 (0.70–1.39) |
Adjusted for age, sex, race, and initiation of thyroid medication during follow-up period.